Cargando…
Geographical genetic variability: a factor to consider when assessing clinical implications of PRDM9
Autores principales: | Alemany-Schmidt, Alexandra, Navarro-Palou, Maria, Voltes-Cobo, Adrià, Rosell, Jordi, Heine-Suñer, Damià, Picornell, Antònia, Oliver-Bonet, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960062/ https://www.ncbi.nlm.nih.gov/pubmed/24689083 http://dx.doi.org/10.1002/mgg3.56 |
Ejemplares similares
-
Analysis of meiotic recombination in 22q11.2, a region that frequently undergoes deletions and duplications
por: Torres-Juan, Laura, et al.
Publicado: (2007) -
Differential epigenetic regulation between the alternative promoters, PRDM1α and PRDM1β, of the tumour suppressor gene PRDM1 in human multiple myeloma cells
por: Romero-García, Raquel, et al.
Publicado: (2020) -
Pinpointing the PRDM9-PRDM7 Gene Duplication Event During Primate Divergence
por: Heerschop, Sacha, et al.
Publicado: (2021) -
Exploring the putative role of PRDM1 and PRDM2 transcripts as mediators of T lymphocyte activation
por: Di Zazzo, Erika, et al.
Publicado: (2023) -
The complex binding of PRDM9
por: Ségurel, Laure
Publicado: (2013)